Sinai Intellectual Property Co Cedars is 10% at Prometheus Biosciences, Inc. (RXDX). They have made 1 open-market trade across 1 company since 2023, most recently 2023-03-08.
CIK 0001868047
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RXDX | 4,001,132 | $799.9M |
Shares reported on the most recent Form 4, priced at the 2023-03-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXDX | SELL | 2023-03-08 | 2023-03-08 | $114.59 | $99.1M | -6.1% | -7.4% | +62.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.